ATE286253T1 - Methoden zur diagnose oder prognose der alzheimerschen krankheit - Google Patents
Methoden zur diagnose oder prognose der alzheimerschen krankheitInfo
- Publication number
- ATE286253T1 ATE286253T1 AT99971091T AT99971091T ATE286253T1 AT E286253 T1 ATE286253 T1 AT E286253T1 AT 99971091 T AT99971091 T AT 99971091T AT 99971091 T AT99971091 T AT 99971091T AT E286253 T1 ATE286253 T1 AT E286253T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- alzheimer
- subject
- activity
- level
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 238000004393 prognosis Methods 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 4
- 108010061642 Cystatin C Proteins 0.000 abstract 2
- 238000013518 transcription Methods 0.000 abstract 2
- 230000035897 transcription Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003862 health status Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10545898P | 1998-10-23 | 1998-10-23 | |
| US10743498P | 1998-11-06 | 1998-11-06 | |
| EP99101377A EP1024364A1 (de) | 1999-01-26 | 1999-01-26 | Methoden zur Diagnose oder Prognose von Alzheimer |
| PCT/EP1999/008023 WO2000025138A2 (en) | 1998-10-23 | 1999-10-22 | Methods of diagnosing or prognosing alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE286253T1 true ATE286253T1 (de) | 2005-01-15 |
Family
ID=27239924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99971091T ATE286253T1 (de) | 1998-10-23 | 1999-10-22 | Methoden zur diagnose oder prognose der alzheimerschen krankheit |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090023145A1 (de) |
| EP (1) | EP1123509B1 (de) |
| JP (1) | JP2002531063A (de) |
| AT (1) | ATE286253T1 (de) |
| AU (1) | AU1153300A (de) |
| DE (1) | DE69922987T2 (de) |
| ES (1) | ES2235550T3 (de) |
| WO (1) | WO2000025138A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6506564B1 (en) | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| GB0012123D0 (en) * | 2000-05-20 | 2000-07-12 | Univ Dundee | Alzheimer's disease assay |
| WO2002002824A1 (en) * | 2000-07-03 | 2002-01-10 | University Of South Florida | Methods and assays for diagnosing alzheimer's disease |
| EP1394549A1 (de) * | 2002-08-23 | 2004-03-03 | Bayer HealthCare AG | Biomarker zur Diagnose von Alzheimer Erkrankung |
| CA2745724C (en) * | 2002-08-23 | 2015-06-02 | Bayer Schering Pharma Aktiengesellschaft | Biomarkers comprising peptide sequence vnhvtlsqpk for diagnosing alzheimer's disease |
| AU2003283303A1 (en) * | 2002-11-08 | 2004-06-07 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) |
| EP1426767A1 (de) * | 2002-12-04 | 2004-06-09 | Bayer HealthCare AG | Diagnostika und Therapeutika für mit humanen Phosphodiesterase 4c (PDE4C) assozierten Krankheiten |
| US7794948B2 (en) | 2003-11-07 | 2010-09-14 | Vermilllion, Inc. | Biomarkers for alzheimer's disease |
| CN104383556B (zh) * | 2007-05-16 | 2018-06-05 | 布里格姆妇女医院 | 突触核蛋白病的治疗 |
| KR102572009B1 (ko) * | 2020-10-21 | 2023-08-29 | 순천향대학교 산학협력단 | 시스타틴 c를 포함하는 퇴행성 신경 질환 진단용 바이오마커 조성물 및 이의 용도 |
| CN115612728A (zh) * | 2021-07-16 | 2023-01-17 | 深圳先进技术研究院 | 一种神经退行性疾病标志物及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2711201C3 (de) * | 1977-03-15 | 1980-06-12 | 7800 Freiburg | Verfahren zur Überprüfen der Harnstoffwerte im menschlichen Körper |
-
1999
- 1999-10-22 JP JP2000578661A patent/JP2002531063A/ja active Pending
- 1999-10-22 AU AU11533/00A patent/AU1153300A/en not_active Abandoned
- 1999-10-22 WO PCT/EP1999/008023 patent/WO2000025138A2/en not_active Ceased
- 1999-10-22 ES ES99971091T patent/ES2235550T3/es not_active Expired - Lifetime
- 1999-10-22 DE DE69922987T patent/DE69922987T2/de not_active Expired - Lifetime
- 1999-10-22 AT AT99971091T patent/ATE286253T1/de active
- 1999-10-22 EP EP99971091A patent/EP1123509B1/de not_active Expired - Lifetime
-
2007
- 2007-10-31 US US11/979,234 patent/US20090023145A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1123509B1 (de) | 2004-12-29 |
| US20090023145A1 (en) | 2009-01-22 |
| WO2000025138A3 (en) | 2000-08-24 |
| DE69922987D1 (de) | 2005-02-03 |
| WO2000025138A2 (en) | 2000-05-04 |
| JP2002531063A (ja) | 2002-09-24 |
| DE69922987T2 (de) | 2006-05-04 |
| ES2235550T3 (es) | 2005-07-01 |
| EP1123509A2 (de) | 2001-08-16 |
| AU1153300A (en) | 2000-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LEMESHOW et al. | Refining intensive care unit outcome prediction by using changing probabilities of mortality | |
| DE60233485D1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
| WO2004046729A3 (en) | Bodily fluid markers of tissue hypoxia | |
| ATE283487T1 (de) | Verfahren zur diagnose oder prognose von altersbedingter maculadegeneration | |
| DE69922987D1 (de) | Methoden zur diagnose oder prognose der alzheimerschen krankheit | |
| ATE203329T1 (de) | Verfahrens und testsätze zur diagnose periodentahlkrankheiten und zur vorhersage des risikos der progression davon | |
| DE60332538D1 (de) | Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen | |
| WO2000004187A3 (en) | Methods and kits for diagnosing and determination of the predisposition of diseases | |
| ATE502119T1 (de) | Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna | |
| AU2003263834A1 (en) | Mutations in nod2 are associated with fibrostenosing disease in patients with crohn's disease | |
| ATE312946T1 (de) | Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten | |
| WO1998001738A3 (en) | Identification of abnormalities in the expression of t and b cell antigen receptors as disease indicators | |
| KR20210109213A (ko) | 알츠하이머병 경도인지장애의 진단 또는 알츠하이머병 치매로의 진행 위험성 예측 방법 | |
| FR2780791B1 (fr) | Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre | |
| ATE375404T1 (de) | Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose | |
| DE60038614D1 (de) | Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen | |
| DE60033646D1 (de) | Methoden zur diagnostizierung oder zur behandlung der alzheimer-krankheit | |
| KR20210109216A (ko) | 알츠하이머병 치매의 발병 위험성 예측을 위한 후성 유전학적 진단 키트 개발 | |
| ATE343793T1 (de) | Methode zur diagnostizierung, prognose oder evaluation von behandlung der depressionen, basiert auf erhöhte neurotrophin concentrationen in zerebrospinale flüssigkeit. | |
| ATE485515T1 (de) | Verfahren zur diagnose einer person mit multipler sklerose | |
| JP7627904B2 (ja) | 腎細胞癌の診断マーカー及びそれを用いた診断方法 | |
| KR102313457B1 (ko) | 알츠하이머병 치매 특이적 유전자 nhlrc4 및 이를 이용한 알츠하이머병 치매 예측 | |
| ATE392622T1 (de) | Verfahren zur diagnose von leberfibrose | |
| KR101289114B1 (ko) | 조기발병하는 상염색체 열성 축삭형 샤르코-마리-투스병의 원인 유전자로서 hadhb 돌연변이 유전자, 이를 이용한 상기 질병의 진단방법 및 진단용 조성물 | |
| Watt et al. | DNA and Huntington's chorea1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1123509 Country of ref document: EP |